Cite
HARVARD Citation
Bataller, A. et al. (2020). Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease. British journal of haematology. pp. 52-61. [Online].